Explore more publications!
Potomac Health News
Got News to Share?

Press Releases

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
January 9, 2026

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire, Inc.
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
January 9, 2026

NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

Indeterminate GlobeNewswire, Inc.
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
January 9, 2026

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones

Indeterminate GlobeNewswire, Inc.
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
January 8, 2026

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

Indeterminate GlobeNewswire, Inc.
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
January 8, 2026

Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology

Indeterminate GlobeNewswire, Inc.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
January 8, 2026

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

Indeterminate GlobeNewswire, Inc.
Flare Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026

Flare Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
NervGen Pharma Begins Trading on Nasdaq Today
January 8, 2026

NervGen Pharma Begins Trading on Nasdaq Today

Indeterminate GlobeNewswire, Inc.
Tris Pharma Announces Acceptance of New Publication Highlighting Promise of Dual NOP-MOP (dual-NMR) Agonists for the Treatment of Moderate-to-Severe Pain
January 8, 2026

Tris Pharma Announces Acceptance of New Publication Highlighting Promise of Dual NOP-MOP (dual-NMR) Agonists for the Treatment of Moderate-to-Severe Pain

Indeterminate GlobeNewswire, Inc.
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
January 8, 2026

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026
January 7, 2026

FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Indeterminate GlobeNewswire, Inc.
Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody
January 7, 2026

Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody

Indeterminate GlobeNewswire, Inc.
Brain & Behavior Research Foundation Highlights Top Mental Health Research Breakthroughs of 2025
January 7, 2026

Brain & Behavior Research Foundation Highlights Top Mental Health Research Breakthroughs of 2025

Indeterminate GlobeNewswire, Inc.
Joint Commission Opens 2026 Award Applications to Recognize Excellence in Healthcare Quality and Patient Safety
January 6, 2026

Joint Commission Opens 2026 Award Applications to Recognize Excellence in Healthcare Quality and Patient Safety

Indeterminate GlobeNewswire, Inc.
Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026
January 6, 2026

Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026

Indeterminate GlobeNewswire, Inc.
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
January 6, 2026

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

Indeterminate GlobeNewswire, Inc.
Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health
January 5, 2026

Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health

Indeterminate GlobeNewswire, Inc.
KeifeRx to Present at Sachs Neuroscience Forum and Biotech Showcase During J.P. Morgan Healthcare Conference Week
January 5, 2026

KeifeRx to Present at Sachs Neuroscience Forum and Biotech Showcase During J.P. Morgan Healthcare Conference Week

Neutral EIN Presswire
Chiro One Wellness Centers Announces Reopening of its Sun Prairie, WI Location as Part of Nationwide Growth
January 5, 2026

Chiro One Wellness Centers Announces Reopening of its Sun Prairie, WI Location as Part of Nationwide Growth

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions